11:54 AM EST - Zymeworks Inc. : Announced that the underwriters of its initial public offering have given notice of their intention to exercise their over-allotment option by purchasing an additional 394,467 common shares at a price of $13.00 U.S. per share, for additional gross proceeds to Zymeworks of $5,128,071 U.S. Closing of the partial exercise of the over-allotment option is expected to occur on Wednesday, May 31. Zymeworks Inc.
shares T.ZYME are trading unchanged at $17.67.
